Anti cancer virotherapy well tolerated in first human administration, research finds
An international medical conference here heard that an Australian developed anti-cancer therapy based on the use of a common cold virus to control cancer cell growth has begun safety testing in human subjects. The research was presented to the third International Meeting on Replicating Oncolytic Virus Therapeutics, on Friday 11 March by Newcastle University associate professor, Darren Sha...Radiation Therapy for Prostate Cancer Tolerated Well by Elderly Patients
Researchers from the University of Pittsburgh Medical Center treated 33 prostate cancer patients, over age 80, with external beam radiation therapy. // Patients received the same radiation doses that patients in their 50s and 60s receive. Results of the study show the elderly patients had a five-year survival rate of more than 60 percent. Researchers say these patients experienced no unu...Precautious Measure Help Tolerate Nausea In Patients
Researchers at the Wake Forest University School of Medicine and colleagues finds it’s better to inform the patients who undergo difficult medical procedures //about the dizzy feel of nausea previously. ‘A person’s expectations can strongly affect how they respond to adversity – both subjectively and physiologically,’ said lead author Max E. Levine, Ph.D. ‘Being prepared for difficult...Alcohol Injections to Tolerate Mortons Neuroma
According to a recent study conducted by researchers at the Royal National Orthopaedic Hospital and Kingston Hospital NHS Trust in Middlesex, United Kingdom. alcohol injections has a high success rate and is well tolerated by patients with Mortons neuroma, a common cause of foot pain. Mortons neuroma is a growth of nerve tissue that occurs in a nerve in your foot, often between you...Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
Patients Using ROX-888 Required Significantly Less Morphine AfterMajor Abdominal Surgery Company On Track To File NDA In 2008 MENLO PARK, CA (June 6, 2007) – ROXROPHARMA Inc. said today that ROX-888, its novel intranasalanalgesic, rapidly and effectively eased pain and was welltolerated by patients who had undergone major abdominal surgery ina Phase 3 clinical study....Data Suggest that Pegasys May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron
WASHINGTON--(BUSINESS WIRE)--May 21, 2007 - Roche today announcedresults of a small study demonstrating that all patients whodiscontinued treatment with Peg-Intron(R) (peginterferon alfa-2b)and ribavirin due to adverse events within the first 12 weeks, wereable to complete 12 weeks of treatment with PEGASYS(R)(peginterferon alfa-2a) and ribavirin. Furthermore, 92 percent ofthese patients we...